Lyme disease vaccination: safety first - author's reply.
Publication
, Journal Article
Lantos, PM
Published in: Lancet Infect Dis
January 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Infect Dis
DOI
EISSN
1474-4457
Publication Date
January 2014
Volume
14
Issue
1
Start / End Page
13
Location
United States
Related Subject Headings
- Microbiology
- Male
- Lyme Disease Vaccines
- Lipoproteins
- Humans
- Female
- Borrelia burgdorferi
- Bacterial Vaccines
- Bacterial Outer Membrane Proteins
- Antigens, Surface
Citation
APA
Chicago
ICMJE
MLA
NLM
Lantos, P. M. (2014). Lyme disease vaccination: safety first - author's reply. Lancet Infect Dis, 14(1), 13. https://doi.org/10.1016/S1473-3099(13)70346-3
Lantos, Paul M. “Lyme disease vaccination: safety first - author's reply.” Lancet Infect Dis 14, no. 1 (January 2014): 13. https://doi.org/10.1016/S1473-3099(13)70346-3.
Lantos PM. Lyme disease vaccination: safety first - author's reply. Lancet Infect Dis. 2014 Jan;14(1):13.
Lantos, Paul M. “Lyme disease vaccination: safety first - author's reply.” Lancet Infect Dis, vol. 14, no. 1, Jan. 2014, p. 13. Pubmed, doi:10.1016/S1473-3099(13)70346-3.
Lantos PM. Lyme disease vaccination: safety first - author's reply. Lancet Infect Dis. 2014 Jan;14(1):13.
Published In
Lancet Infect Dis
DOI
EISSN
1474-4457
Publication Date
January 2014
Volume
14
Issue
1
Start / End Page
13
Location
United States
Related Subject Headings
- Microbiology
- Male
- Lyme Disease Vaccines
- Lipoproteins
- Humans
- Female
- Borrelia burgdorferi
- Bacterial Vaccines
- Bacterial Outer Membrane Proteins
- Antigens, Surface